NYMOX PHARMACEUTICAL CORP Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NYMOX PHARMACEUTICAL CORP for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.23 | 5,300 | 17,119 | 3,128,550 | 3.1 M to 3.1 M (+0.17 %) |
| Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.22 | 700 | 2,254 | 3,123,250 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.23 | 5,300 | 17,119 | 3,128,550 | 3.1 M to 3.1 M (+0.17 %) |
| Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.22 | 700 | 2,254 | 3,123,250 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 20 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 3,941 | 12,895 | 3,122,550 | 3.1 M to 3.1 M (+0.13 %) |
| Feb 20 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 3,059 | 10,026 | 3,118,609 | 3.1 M to 3.1 M (+0.10 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 1,000 | 3,330 | 3,115,550 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.32 | 500 | 1,660 | 3,114,550 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 100 | 331 | 3,114,050 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 200 | 660 | 3,113,950 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 100 | 329 | 3,113,750 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 100 | 328 | 3,113,650 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.26 | 100 | 326 | 3,113,550 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.25 | 5,600 | 18,222 | 3,113,450 | 3.1 M to 3.1 M (+0.18 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.25 | 300 | 975 | 3,107,850 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.18 | 5,374 | 17,103 | 3,107,550 | 3.1 M to 3.1 M (+0.17 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 200 | 635 | 3,102,176 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 300 | 951 | 3,101,976 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 100 | 317 | 3,101,676 | 3.1 M to 3.1 M (0.00 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 68 | 215 | 3,101,576 | 3.1 M to 3.1 M (0.00 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 158 | 500 | 3,101,508 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 800 | 2,532 | 3,101,350 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.42 | 4,900 | 16,758 | 3,100,550 | 3.1 M to 3.1 M (+0.16 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.38 | 100 | 338 | 3,095,650 | 3.1 M to 3.1 M (0.00 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.37 | 500 | 1,685 | 3,095,550 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.36 | 900 | 3,024 | 3,095,050 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 1,000 | 3,350 | 3,094,150 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 600 | 1,986 | 3,093,150 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 100 | 330 | 3,092,550 | 3.1 M to 3.1 M (0.00 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 1,400 | 4,606 | 3,092,450 | 3.1 M to 3.1 M (+0.05 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 500 | 1,640 | 3,091,050 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.47 | 5,000 | 17,350 | 3,090,550 | 3.1 M to 3.1 M (+0.16 %) |